학술논문

Inheritance of deleterious mutations at both BRCA1 and BRCA2 in an international sample of 32,295 women.
Document Type
article
Author
Rebbeck, Timothy RFriebel, Tara MMitra, NanditaWan, FeiChen, StephanieAndrulis, Irene LApostolou, ParaskeviArnold, NorbertArun, Banu KBarrowdale, DanielBenitez, JavierBerger, RaananBerthet, PascalineBorg, AkeBuys, Saundra SCaldes, TrinidadCarter, JonathanChiquette, JocelyneClaes, Kathleen BMCouch, Fergus JCybulski, CezaryDaly, Mary Bde la Hoya, MiguelDiez, OrlandDomchek, Susan MNathanson, Katherine LDurda, KatarzynaEllis, SteveEMBRACEEvans, D GarethForetova, LenkaFriedman, EitanFrost, DebraGanz, Patricia AGarber, JudyGlendon, GordGodwin, Andrew KGreene, Mark HGronwald, JacekHahnen, EricHallberg, EmilyHamann, UteHansen, Thomas VOHEBONImyanitov, Evgeny NIsaacs, ClaudineJakubowska, AnnaJanavicius, RamunasJaworska-Bieniek, KatarzynaJohn, Esther MKarlan, Beth YKaufman, BellaInvestigators, KConFabKwong, AvaLaitman, YaelLasset, ChristineLazaro, ConxiLester, JennyLoman, NiklasLubinski, JanManoukian, SiranoushMitchell, GillianMontagna, MarcoNeuhausen, Susan LNevanlinna, HeliNiederacher, DieterNussbaum, Robert LOffit, KennethOlah, EdithOlopade, Olufunmilayo IPark, Sue KyungPiedmonte, MarionRadice, PaoloRappaport-Fuerhauser, ChristineRookus, Matti ASeynaeve, CarolineSimard, JacquesSinger, Christian FSoucy, PennySouthey, MelissaStoppa-Lyonnet, DominiqueSukiennicki, GrzegorzSzabo, Csilla ITancredi, MariellaTeixeira, Manuel RTeo, Soo-HwangTerry, Mary BethThomassen, MadsTihomirova, LaimaTischkowitz, MarcToland, Amanda EwartToloczko-Grabarek, AleksandraTung, Nadinevan Rensburg, Elizabeth JVillano, DanyloWang-Gohrke, ShanWappenschmidt, BarbaraWeitzel, Jeffrey NZidan, JamalZorn, Kristin K
Source
Breast cancer research : BCR. 18(1)
Subject
EMBRACE
HEBON
Humans
Breast Neoplasms
Population Surveillance
Heterozygote
Phenotype
Loss of Heterozygosity
Germ-Line Mutation
Alleles
Genes
BRCA1
Genes
BRCA2
Exons
Female
Promoter Regions
Genetic
BRCA1
BRCA2
Hereditary breast and ovarian cancer
Transheterozygosity
Genes
Promoter Regions
Genetic
Clinical Research
Breast Cancer
Cancer
2.1 Biological and endogenous factors
Oncology & Carcinogenesis
Oncology and Carcinogenesis
Language
Abstract
BackgroundMost BRCA1 or BRCA2 mutation carriers have inherited a single (heterozygous) mutation. Transheterozygotes (TH) who have inherited deleterious mutations in both BRCA1 and BRCA2 are rare, and the consequences of transheterozygosity are poorly understood.MethodsFrom 32,295 female BRCA1/2 mutation carriers, we identified 93 TH (0.3 %). "Cases" were defined as TH, and "controls" were single mutations at BRCA1 (SH1) or BRCA2 (SH2). Matched SH1 "controls" carried a BRCA1 mutation found in the TH "case". Matched SH2 "controls" carried a BRCA2 mutation found in the TH "case". After matching the TH carriers with SH1 or SH2, 91 TH were matched to 9316 SH1, and 89 TH were matched to 3370 SH2.ResultsThe majority of TH (45.2 %) involved the three common Jewish mutations. TH were more likely than SH1 and SH2 women to have been ever diagnosed with breast cancer (BC; p = 0.002). TH were more likely to be diagnosed with ovarian cancer (OC) than SH2 (p = 0.017), but not SH1. Age at BC diagnosis was the same in TH vs. SH1 (p = 0.231), but was on average 4.5 years younger in TH than in SH2 (p